Morpholine Methyltetralone (Shenyang Pharmaceutical University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMorpholine Methyltetralone (Shenyang Pharmaceutical University)
Drug Alias NameCY (Shenyang Pharmaceutical University)morpholine methyltetralone
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel modulators
TargetsPotassium channel
Therapy Area/IndicationsGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenyang Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A